A retrospective survey was conducted to characterize -lactamases in a collection of 43 ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from patients with bloodstream infections hospitalized at a Brazilian teaching hospital between January and December 2005. Resistance rates for carbapenems, aminoglycosides, and quinolones were over 80%, with only colistin remaining active against all isolates. Pulsed-field gel electrophoresis analysis identified seven different genotypes. AmpC overproduction was found to be the sole -lactamase-mediated mechanism responsible for ceftazidime resistance in four isolates (9.3%). Nine isolates (20.9%) produced an extended-spectrum -lactamase (ESBL), either GES-1 (n ؍ 7, 16.3%) or CTX-M-2 (n ؍ 2, 4.6%). Carbapenemase activity was detected in 30 (70%) additional isolates. Among those isolates, two isolates (4.6%) produced the ESBL GES-5, possessing the ability to hydrolyze imipenem; a single isolate (2.3%) produced the metallo--lactamase (MBL) IMP-1; and 27 isolates produced the MBL SPM-1 (62.8%). None of the isolates coproduced both ESBL and MBL. Insertion sequence elements ISCR4 and ISCR1 were associated with bla SPM-1 and bla CTX-M-2 genes, respectively, whereas the bla GES-1 and bla GES-5 genes were part of class 1 integron structures. This study underlines the spread of MBL-and ESBL-producing P. aeruginosa isolates as an important source of ceftazidime resistance in Brazil.Pseudomonas aeruginosa is a leading cause of hospitalacquired infections. Acquisition of -lactamases, such as class A extended-spectrum -lactamases (ESBLs) and class B metallo--lactamases (MBLs), by P. aeruginosa nosocomial isolates is detrimental to antimicrobial therapy in hospitalized patients (19).The ESBLs reported for P. aeruginosa are SHV, TEM, PER, VEB, BEL, GES, and, more recently, CTX-M types (1,7,8,16,20,23,29). The GES-type enzymes are unusual since point amino acid changes in their active sites may extend their hydrolytic activity to carbapenems (31,39,40). ESBL production in P. aeruginosa has been documented in Brazil (2, 5, 21), but its prevalence remains unknown.Five types of acquired MBLs have been identified in P. aeruginosa: IMP, VIM, SPM, GIM, and AIM (41, 42). In Brazil, IMP-, VIM-, and SPM-producing P. aeruginosa clinical isolates have been identified (35). In addition, SPM producers have been reported as endemic in Brazilian territory due to dissemination of a single clone (10).The aim of this study was to investigate the diversity and frequency of both ESBL and MBL production and to characterize the genetic support of those acquired -lactamase genes in a collection of ceftazidime-resistant P. aeruginosa clinical isolates from Brazil, taken as a model of a developing country.
MATERIALS AND METHODSBacterial strains. A total of 154 consecutive P. aeruginosa isolates were recovered from patients with bloodstream infections hospitalized at Hospital São Paulo between January and December 2005. A single isolate per patient was retained for this study. Among those isol...